Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Aug;20(8):504.
doi: 10.1038/s41571-023-00791-w.

Adjuvant osimertinib improves overall survival

Peter Sidaway  1
Affiliations
Comment

Adjuvant osimertinib improves overall survival

Peter Sidaway. Nat Rev Clin Oncol. 2023 Aug.
No abstract available

PubMed Disclaimer

Comment on

  • Overall Survival with Osimertinib in Resected EGFR-Mutated NSCLC.
    Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohé C, Wang J, Goldman JW, Lu S, Su WC, de Marinis F, Shepherd FA, Lee KH, Le NT, Dechaphunkul A, Kowalski D, Poole L, Bolanos A, Rukazenkov Y, Wu YL; ADAURA Investigators. Tsuboi M, et al. N Engl J Med. 2023 Jul 13;389(2):137-147. doi: 10.1056/NEJMoa2304594. Epub 2023 Jun 4. N Engl J Med. 2023. PMID: 37272535 Clinical Trial.

References

Original article
    1. Tsuboi, M. et al. Overall survival with osimertinib in resected EGFR-mutated NSCLC. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2304594 (2023) - DOI - PubMed

MeSH terms

LinkOut - more resources